News
Mumbai-based art collector Abeer Vivek Abrol, a graduate of Sotheby’s Institute of Art in London and New York, made a ...
ATTR-CM is a heart disease that is often undiagnosed and can be fatal. Dr. James Ampadu, a cardiologist with Prisma Health, shares symptoms of ATTR-CM. Ian, who was diagnosed with ATTR-CM, also shares ...
However, few medicines are approved for ATTR-wt. GlobalData estimates that vutrisiran’s entrance into the ATTR-wt market will ...
The FDA Commissioner Marty Makary stated the FDA will reach its 2025 drug approval targets despite severe workforce ...
Fraud cases involving internet and cards in the banking sector fell by more than 50% in FY25 over the corresponding year (FY24). It comes a y.
Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) has been approved by the European Commission (EC) to treat adults with ...
Amvuttra is the first and only RNA interference (RNAi) therapeutic approved by the EC for both the cardiomyopathy and the ...
The drug is already approved in the EU for transthyretin amyloidosis with polyneuropathy but now covers patients with cardiomyopathy.
Alnylam said the green light makes Amvuttra the first and only RNAi therapeutic approved in Europe for the treatment of the cardiomyopathy manifestations of ATTR amyloidosis and the polyneuropathy ...
Manipur has been hit by heavy rainfall-induced flood, which many organisations in Imphal Valley attribute to the ...
H.C. Wainwright’s Patrick Trucchio reiterated his Buy rating on Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) and raised his ...
The Times’ recent front-page reporting on the mysteriously “closed for renovations” Governor’s Inn, owned by a prominent GOP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results